Given that MLL/AF9 cells have the main dependence on OXPHOS, and to develop a novel strategy for treating MLL/AF9 AML, we therefore evaluated the effect of metformin on MLL/AF9 cell proliferation. This evidence concerns the gene KMT2A and acute myeloid leukemia.